Recently, many single-tracer tau PET datasets have accumulated across clinical trials and publicly available sources, making tau PET harmonization imperative for comparing results across studies and conducting large-scale analyses of tau PET in AD. The gene discussed is MAPT; the disease is Alzheimer disease.